Screening, Brief Intervention, and Referral to Treatment for Drug Use

NCT ID: NCT01683227

Last Updated: 2016-04-19

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 700 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2010-04-30
• Study Completion Date: 2012-08-31

Brief Summary

Screening, Brief Intervention, and Referral to Treatment (SBIRT) is a comprehensive, integrated public health approach to identify and deliver a spectrum of early detection and intervention services for substance use in general medical care settings. These settings, such as emergency department visits, offer a potential "teachable moment" because patients may have perceptions of vulnerability about their health, and therefore be particularly receptive to screening and counseling. There is mounting scientific evidence suggesting SBIRT is effective in reducing alcohol use at varying levels of severity in a myriad of health care settings including primary care, emergency departments, and trauma centers. Although the SBIRT approach has shown promise for alcohol, relatively little is known about its effectiveness for adult illicit drug use specifically.

This will be among the first studies to rigorously test the SBIRT approach for drug use. It will evaluate the effectiveness of SBIRT for drug use and related factors for 700 multi-ethnic ED patients using a two-group randomized repeated-measures design in which biologically-validated drug use abstinence and related outcomes of an intervention group are compared to those of an attention-placebo control group. Over a 14-month period, bilingual/bicultural Health Educators recruited participants who reported past 30-day illicit drug use in excess of risky alcohol use from the waiting areas of two large hospital's ED and trauma units. Following consent procedures and standardized baseline assessments, Health Educators randomly assigned participants to one of the two conditions. The intervention group received "Life Shift," an SBIRT drug use intervention matched to the participant's drug use risk level. The control group received the same type and quantity of intervention in an unrelated area-Driving and Traffic Safety ("Shift Gears" program), also matched to their driving/traffic risk level. A 6-month face-to-face follow-up visit by trained measurement technicians blind to the participant's assigned condition collected standardized self-report past 30-day drug use measures (ASI-Lite)and hair samples for validating self-reported abstinence. Additional outcome variables are changes in the frequency of drug use, functional status measures (i.e., medical problems, psychiatric problems, and alcohol use), and health care utilization.

Conditions

Drug Abuse

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: FACTORIAL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: DOUBLE

Study Groups

Screening/motivational drug intervention

Screening and brief intervention counseling matched to patient's risk level delivered in the ER

Group Type: EXPERIMENTAL

Screening/motivational drug intervention

Intervention Type: BEHAVIORAL

Screening and brief motivational intervention delivered in the ER to reduce drug use

Motivational placebo intervention

Screening and brief intervention for driving and traffic safety

Group Type: PLACEBO_COMPARATOR

Motivational placebo intervention

Intervention Type: BEHAVIORAL

Screening and brief motivational intervention delivered in the ER to reduce driving and traffic risk

Interventions

Screening/motivational drug intervention

Screening and brief motivational intervention delivered in the ER to reduce drug use

Intervention Type: BEHAVIORAL

Motivational placebo intervention

Screening and brief motivational intervention delivered in the ER to reduce driving and traffic risk

Intervention Type: BEHAVIORAL

Other Intervention Names

SBIRT

Eligibility Criteria

Inclusion Criteria

• 18 or over
• speak English or Spanish
• competent to give consent and interact
• drug use risk higher than alcohol use risk

Exclusion Criteria

• under 18
• non english or spanish speaker
• no telephone where one can be reached
• too injured/sick to participate
• alcohol use risk higher than drug use risk

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 100 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

San Diego State University

OTHER

Sponsor Role: lead

Responsible Party

Susan I. Woodruff

Professor

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Susan I Woodruff, PhD

Role: PRINCIPAL_INVESTIGATOR

San Diego State University, School of Social Work

Locations

Scripps Mercy Emergency Department and Trauma Unit

San Diego, California, United States

UCSD Emergency Department and Trauma Unit

San Diego, California, United States

Countries

United States

References

Woodruff SI, Clapp JD, Eisenberg K, McCabe C, Hohman M, Shillington AM, Sise CB, Castillo EM, Chan TC, Sise MJ, Gareri J. Randomized clinical trial of the effects of screening and brief intervention for illicit drug use: the Life Shift/Shift Gears study. Addict Sci Clin Pract. 2014 May 22;9(1):8. doi: 10.1186/1940-0640-9-8.

Reference Type: DERIVED

PMID: 24886786 (View on PubMed)

Eisenberg K, Woodruff SI. Randomized controlled trial to evaluate screening and brief intervention for drug-using multiethnic emergency and trauma department patients. Addict Sci Clin Pract. 2013 Apr 8;8(1):8. doi: 10.1186/1940-0640-8-8.

Reference Type: DERIVED

PMID: 23566363 (View on PubMed)

Other Identifiers

1RC1DA028031-01

Identifier Type: NIH

Identifier Source: org_study_id

View Link